GANX
Gain Therapeutics Inc
NASDAQ: GANX · HEALTHCARE · BIOTECHNOLOGY
$1.76
-4.86% today
Updated 2026-04-29
Market cap
$83.70M
P/E ratio
—
P/S ratio
255.50x
EPS (TTM)
$-0.61
Dividend yield
—
52W range
$1 – $4
Volume
0.7M
Gain Therapeutics Inc (GANX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+5.8%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-37.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+5.8%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+11.6%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-19 | $-0.11 | +23.8% | $1.95 | $1.95 | +0.0% |
| 2025-11-12 | $-0.15 | +0.0% | $2.68 | $2.99 | +11.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.14 | $-0.11 | +23.8% | — | — |
| 2025-09-30 | $-0.15 | $-0.15 | +0.0% | — | — |
| 2025-06-30 | $-0.17 | $-0.19 | -11.8% | — | — |
| 2025-03-31 | $-0.18 | $-0.16 | +11.1% | — | — |
| 2024-12-31 | $-0.19 | $-0.08 | +57.3% | $82242.00 | +26.9% |
| 2024-09-30 | $-0.21 | $-0.17 | +19.0% | — | — |
| 2024-06-30 | $-0.20 | $-0.42 | -110.0% | — | — |
| 2024-03-31 | $-0.29 | $-0.22 | +24.1% | — | — |
| 2023-12-31 | $-0.32 | $-0.36 | -12.5% | $64800.00 | — |
| 2023-09-30 | $-0.45 | $-0.37 | +17.8% | — | — |
| 2023-06-30 | $-0.31 | $-0.62 | -100.0% | — | — |
| 2023-03-31 | $-0.39 | $-0.43 | -10.3% | $55180.00 | — |
Frequently asked questions
Has Gain Therapeutics Inc beaten earnings estimates?
Gain Therapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +5.8% over the last 4 quarters.
How does GANX stock react to earnings?
GANX stock has moved an average of +5.8% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.